Literature DB >> 12076825

Cell-binding properties of glycoprotein B of Aujeszky's disease virus.

Veronika V Vrublevskaya1, Aleksey N Kornev, Sergey V Smirnov, Oleg S Morenkov.   

Abstract

The glycoprotein B (gB) of Aujeszky's disease virus (ADV) has a role in virus entry and cell-to-cell spread. In this report we examined the cell-binding properties of native ADV gB purified from the virus envelope by affinity chromatography. The binding of gB to the surface of susceptible cells BHK-21 and MDBK was specific, dose-dependent, and nearly saturable, which is characteristic of conventional receptor-ligand interactions. The purified gB was shown to specifically bind to immobilised heparin. The addition of soluble exogenous heparin and heparinase treatment of cells inhibited the binding of gB to the cells. Cell-associated gB could also be dissociated from the cells by soluble heparin. The results indicated that ADV gB binds specifically to cellular heparan sulphate. The binding of gB to cells inhibited the attachment of virus to cells and thus the formation of viral plaques. The results suggest that ADV gB may have a function in the initial attachment of ADV to the surface of susceptible cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076825     DOI: 10.1016/s0168-1702(02)00032-1

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  3 in total

1.  Initial evidence on differences among Enterovirus 71, Coxsackievirus A16 and Coxsackievirus B4 in binding to cell surface heparan sulphate.

Authors:  Hamid Reza Pourianfar; Kristin Kirk; Lara Grollo
Journal:  Virusdisease       Date:  2013-12-04

2.  Classification of viral zoonosis through receptor pattern analysis.

Authors:  Se-Eun Bae; Hyeon Seok Son
Journal:  BMC Bioinformatics       Date:  2011-04-13       Impact factor: 3.169

3.  A 2,5-Dihydroxybenzoic Acid-Gelatin Conjugate: The Synthesis, Antiviral Activity and Mechanism of Antiviral Action Against Two Alphaherpesviruses.

Authors:  Alexander Lisov; Veronika Vrublevskaya; Zoy Lisova; Alexey Leontievsky; Oleg Morenkov
Journal:  Viruses       Date:  2015-10-15       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.